Under the Global Generics segment, Dr. Reddy's manufactures and markets both prescription and over-the-counter pharmaceutical products. These products are available under brand names or as generic versions that have the same therapeutic effects as branded formulations. Additionally, this segment also focuses on the biologics business.
The PSAI segment of the company is responsible for manufacturing and marketing active pharmaceutical ingredients and intermediates. These ingredients are essential components used in the production of finished pharmaceutical products. The segment also offers contract research services and customizes the manufacturing of active pharmaceutical ingredients and steroids based on specific customer requirements.
The Others segment of Dr. Reddy's is involved in the development of therapies in the fields of oncology and inflammation. It also conducts research and development for differentiated formulations. Furthermore, this segment provides digital healthcare services and information technology-enabled business support services.
The company's therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology.
Dr. Reddy's Laboratories Limited was established in 1984 and has its headquarters in Hyderabad, India.